8-KThe WireRoutine
Shareholder Vote
Filed Jun 1, 2018 · 8y ago · Accession 0001437749-18-011058
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing text
View original ↗UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
_______________________
Date of Report
(Date of earliest
event reported):
May 30, 2018
National Research Corporation
(Exact name of registrant as specified in its charter)
Wisconsin
0 01 - 35929
47-0634000
(State or other
jurisdiction of
incorporation)
(Commission File
Number)
(IRS Employer
Identification No.)
1245 Q Street, Lincoln, Nebraska 68508
(Address of principal executive offices, including zip code)
(402) 475-2525
(Registrant’s telephone number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 .
Submission of Matters to a Vote of Security Holders .
On May 30, 2018, National Research Corporation (the “Company”) held its 2018 annual meeting of shareholders (the “Annual Meeting”). At the Annual Meeting, the Company’s shareholders voted on the following proposals:
●
The election of two directors, Michael D. Hays and John N. Nunnelly, to the Company’s Board of Directors for three-year terms to expire at the Company’s 2021 annual meeting of shareholders;
●
The ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for 2018;
●
An advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the proxy statement; and
●
The approval of amendments to the Company’s 2004 Non-Employee Director Stock Plan (the “Plan”).
As of the April 18, 2018 record date for the determination of the shareholders entitled to notice of, and to vote at, the Annual Meeting, 24,608,700 shares of the Company’s common stock were outstanding and eligible to vote. Approximately 97.03% of all shares (and votes) were represented at the Annual Meeting in person or by proxy. The following are the final votes on the matters presented for shareholder consideration at the Annual Meeting:
Election of Directors
The shareholders elected Michael D. Hays and John N. Nunnelly as directors for three-year terms to expire at the Company’s 2021 annual meeting of shareholders. The results of the vote were as follows:
For
Withheld
Broker Non-Votes
Name
Votes
Percentage (1)
Votes
Percentage
Votes
Percentage (2)
Michael D. Hays
22,375,492
99.42%
130,841
0.58%
1,371,647
N/A
John N. Nunnelly
22,230,817
98.78%
275,516
1.22%
1,371,647
N/A
Ratify Appointment of KPMG LLP for 2018
The shareholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for 2018. The results of the vote were as follows:
For
Against
Abstain
Broker Non-Votes
Votes
Percentage (1)
Votes
Percentage (1)
Votes
Percentage ( 2 )
Votes
Percentage (2)
23,425,805
99.65
%
81,780
0.35
%
370,395
N/A
0
N/A
-2-
Advisory Vote to Approve Executive Compensation
The shareholders approved the compensation of the Company’s named executive officers as disclosed in the proxy statement. The results of the advisory vote were as follows:
For
Against
Abstain
Broker Non-Votes
Votes
Percentage (1)
Votes
Percentage (1)
Votes
Percentage ( 2 )
Votes
Percentage (2)
22,315,785
99.41
%
132,139
0.59
%
58,409
N/A
1,371,647
N/A
A pprove A mendments to the Plan
The shareholders approved the proposed amendments to the Plan. The results of the vote were as follows:
For
Against
Abstain
Broker Non-Votes
Votes
Percentage (1)
Votes
Percentage (1)
Votes
Percentage ( 2 )
Votes
Percentage (2)
21,349,285
96.07
%
847,184
3.93
%
282,864
N/A
1,371,647
N/A
_______________
(1) Based on a total of all votes received and eligible to be counted as voted on this proposal at the Annual Meeting.
(2) “N/A” means that abstentions and/or broker non-votes do not have any effect on the voting results on this proposal.
-3-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: June 1, 2018
NATIONAL RESEARCH CORPORATION
By:
/s/ Kevin R. Karas
Kevin R. Karas
Senior Vice President Finance, Chief Financial
Officer, Treasurer and Secretary
-4-
Filing details
- Company
- NRC HEALTH
- Ticker
- NRC
- CIK
- 70487
- Form type
- 8-K
- Filing date
- Jun 1, 2018
- Report date
- May 30, 2018
- Document
- nrc20180531_8k.htm
- Size
- 68 KB